(Scientific Reports, 2020) demonstrated that BPC-157 induces phosphorylation of eNOS at Ser1177 through the SrcCaveolin-1eNOS signaling cascade, reducing inhibitory Cav-1eNOS complex formation and enabling NO production
in vitro and animal studies have linked thymosin beta-4 overexpression to increased tumor size and metastasis in several cancer types (including colorectal and pancreatic cancer), leading researchers to flag a theoretical cancer-promotion risk, particularly for anyone with an active malignancy or recent cancer history Self-reported effects compiled from user and case reports, not controlled trials, include injection-site redness or itching, transient fatigue, and headache
STORE IN A COOL, DRY PLACE.
Reconstituted BPC-157 maintains potency for two to six weeks when properly refrigerated and handled with sterile technique
Because every patient has different needs, treatment recommendations are based on your health history, symptoms, and overall objectives